MedTrace Logo

Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes

NCT02923830 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-06-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in BioFlo implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.

Conditions

  • Obstruction; Catheter, Infusion Catheter (Vascular)
  • Catheter; Complications (Indwelling Catheter)

Interventions

OTHER

Heparinized saline catheter flush

The control group will have their port catheters flushed with 20mL saline + 5mL heparin 100 units/mL; q 3 months

DRUG

Saline-only catheter flush

The intervention group will have their port catheters flushed with saline only.

Sponsors & Collaborators

  • TriHealth Inc.

    lead OTHER

Principal Investigators

  • Sharon Sanker, RN, OCN · TriHealth Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-11-30
Completion
2019-03-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02923830 on ClinicalTrials.gov